Cancer Genetics, Inc. announced as of November 17, 2020, with the departure, on November 16, 2020, of M. Glenn Miles, the former Chief Financial Officer of the Company, John A. Roberts, the current President and Chief Executive Officer of the Company began serving as the Principal Financial Officer and Principal Accounting Officer of the Company. Mr. Roberts shall serve in such positions until his resignation or until a replacement is appointed by the Board of Directors.